Please login to the form below

Not currently logged in

Excellence in New Product Introductions

Sponsored by

Back to Results


Jazz Pharmaceuticals' EU Launch of Sunosi (solriamfetol)

by Jazz Pharmaceuticals
with support from GCI Health, Ashley Medical Communications, Salt and HRW

Summary of work

Excessive daytime sleepiness (EDS) is a debilitating symptom of both narcolepsy and obstructive sleep apnoea (OSA), which affects nearly all aspects of an individual’s daily living, from falling asleep at unexpected times during the day to negatively impacting relationships and day-to-day activities. Despite this, recognition of EDS is low amongst nearly all stakeholders, including treating physicians, payers, and the patients themselves. Jazz identified the existence of a significant unmet need to both treat and provide education on EDS as a serious symptom of narcolepsy and OSA. With the introduction of Jazz’s new treatment, the basic ability for people to stay awake as a result of these conditions has the potential to be realised.
Jazz’s new product launch success can be attributed to extensive market and customer research, spanning two distinct patient and treating populations, and the adaptation of a traditional ‘top-down’ regional launch strategy to a more localised launch plan, ensuring initial successes in specific markets.
Jazz executed high-impact launch activities, injecting energy into ongoing launch success across the EU. Additionally, cross-country collaboration remained core to Jazz’s launch strategy, with learnings shared on a regular basis to overcome barriers and continue to improve patient outcomes by expanding access.

Judges' comments

Jazz Pharmaceuticals’ entry was well-structured and well-written. The judges felt it was great to see the effective use of disease education to support this complex product launch. It had a good blend of top down and localised market input and was candid about the information on work to be done.

Highly commended


ZOLGENSMA® UK Media Launch - by Novartis Gene Therapies
with support from Havas Life Medicom

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022